Islet cell transplantation as a cure for insulin dependent diabetes: Current improvements in preserving islet cell mass and function

Hepatobiliary and Pancreatic Diseases International

Volumn 2, Issue 2, 2003, Pages 170-179

  Fontaine, Magali J ^a   Fan, Weimin ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Graft function; Graft preservation; Islets of Langerhans; Transplantation; Type I diabetes

Indexed keywords

AMINOGUANIDINE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; CYTOKINE; DACLIZUMAB; FREE RADICAL; FUSIDIC ACID; GAMMA INTERFERON; HEPARIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ANTIBODY; INTERLEUKIN 4; MELAGATRAN; MONOCLONAL ANTIBODY; N(G) METHYLARGININE; NICOTINAMIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; RAPAMYCIN; STEROID; TACROLIMUS; THROMBIN INHIBITOR; TISSUE FACTOR PATHWAY INHIBITOR; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULOTROPIN;

APOPTOSIS; CELL DAMAGE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LOSS; CELL PROTECTION; CELL VIABILITY; CYTOKINE RELEASE; CYTOTOXICITY; DIABETES MELLITUS; DIABETOGENESIS; DOWN REGULATION; DRUG POTENTIATION; DRUG TARGETING; GRAFT PRESERVATION; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; ISOLATION PROCEDURE; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PANCREAS ISLET CELL; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET TRANSPLANTATION; PERIOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROTEIN EXPRESSION; REVASCULARIZATION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TREATMENT INDICATION; TREATMENT OUTCOME; UPREGULATION; VEIN THROMBOSIS;

ANIMALS; DIABETES MELLITUS, TYPE 1; GRAFT SURVIVAL; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION;

EID: 0037530273     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Caroll PB. Anatomy and physiology of islets of Langerhans. In: Ricordi C (ed). Pancreatic islet cell transplantation. Austin: R. G. Landes Company. 1992;7-18.
2. Minkowski O. Weitere mittheilungen uber den diabetes mellitus nach exstirpation des pankreas. Berliner Klin Wschr 1892;29-90.
3. Banting FG, Best C. The internal secretion of the pancreas. J Lab Clin Med 1922;7:251-266.
4. Lillehei RC, Simmons RL, Najarian JS. Pancreaticoduodenal allotransplantation: experimental and clinical experience. Am J Surg 1967;172:405-436.
5. Hering BJ, Ricordi C. Islet transplantation for patients with type 1 diabetes. Graft 1999;2:12-27.
6. Najarian JS, Sutherland DER, Matas AJ, et al. Human islet transplantation: a preliminary report. Transplant Proc 1977;9:233-236.
7. Sutherland DER, Gores PF, Farney AC, et al. Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the University of Minnesota. Am J Surgery 1993;166:456-491.
8. Shapiro AMJ, Lakey JRT, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J M 2000;343:230-238.
9. + T lymphocytes in primary non-function and classic rejection of islet allografts. J Exp Med 1990;172:291-302.
10. Kaufman DB, Gores PF, Field MJ, et al. Effect of 15-deoxyspergualin on immediate function and long-term survival of transplanted islets. Diabetes 1994;43:778-783.
11. Rosenberg L, Wang R, Paraskevas S, et al. Structural and functional changes resulting from islet isolation lead to islet cell death. Surgery 1999;126:393-398.
12. Davalli AM, Scaglia L, Zangen DH, et al. Vulnerability of islets in the immediate post-transplantation period. Diabetes 1996;19:1161-1167.
13. Moskalewski S. Isolation and culture of the islets of Langerhans of the guinea pig. Gen Comp Endocrinol 1965;5:342-353.
14. Lacy PE, Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967;16:35-39.
15. Gray DWR, Warnock GL, Sutton R. A method for isolation of islets of Langerhans from the human pancreas. Diabetes 1984;33:1055-1061.
16. Sutton R, Hammonds P, Hughes D. Isolation of islets from human pancreas using increased incubation temperatures and variable density gradients. Horm Metab Res 1989;25:35-36.
17. Ricordi C. The automated method for islet isolation. In: Ricordi C (ed). Pancreatic islet cell transplantation. Austin: R. G. Landes Company. 1992;7-18.
18. Berney T, Molano D, Cattan P, et al. Endotoxin-mediated delayed islet graft function is associated with increased intra-islet cytokine production and islet cell apoptosis. Transplantation 2001;71:125-132.
19. Matsumoto S, Kuroda Y. Perfluorocarbon for organ preservation before transplantation. Transplantation 2002;74:1804-1809.
20. Korsgren O, Chrstofferson R, Jansson L. Angiogenesis and angioarchitecture of transplanted fetal porcine islet-like cell clusters. Transplantation 1999;68:1761-1766.
21. Vajkoczy P, Olofsson AM, Lehr HA, et al. Histogenesis and ultrastructure of pancreatic islet graft microvasculature. Evidence for graft revascularization by endothelial cells of host origin. Am J of Pathol 1995;146: 1397-1405.
22. Vasir B, Aiello LP, Yoon KH, et al. Hypoxia induces vascular endothelial growth factor gene protein expression in cultured rat islet cells. Diabetes 1998;47:1894-1903.
23. Gorden DL, Mandriota SJ, Montesano R, et al. Vascular endothelial growth factor is increased in devascularized rat islets of Langerhans in vitro. Transplantation 1997;63:436-443.
24. Oberg C, Waltenberger J, Claesson-Welsh L. Expression of protein tyrosine kinases in islet cells: possible role of the Flk-1 receptor for beta-cell maturation from duct cells. Growth Factors 1994;10:115-126.
25. Biarnes M, Montolio M, Nacher V, et al. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 2002;51:66-72.
26. Vasir B, Jonas JC, Steil GM, et al. Gene expression of VEGF and its receptors Flk-1/KDR and Flt-1 in cultured and transplanted rat islets. Transplantation 2001;71:924-935.
27. Hirshberg B, Montgomery S, Wysoki MG, et al. Pancreatic islet transplantation using the nonhuman primate (rhesus) model predicts that the portal vein is superior to the celiac artery as the islet infusion site. Diabetes 2002;51:2135-2140.
28. Bennett W, Sundberg B, Groth CG, et al. Incompatibility between human blood and isolated islets of Langerhans. Diabetes 1999;48:1907-1914.
29. Ozmen L, Nilsson-Ekdahl K, Elgue G, et al. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets. Diabetes 2002;51:1779-1784.
30. Thomas HE, Darwiche R, Corbett JA, et al. Interleukin-1 plus γ-interferon-induced pancreatic β-cell dysfunction is mediated by β-cell nitric oxide production. Diabetes 2002;51:311-316.
31. Pukel C, Baquerizo H, Rabinovitch A. Destruction of rat islet cell monolayers by cytokines: synergistic interactions of interferon-γ, tumor necrosis factor, lymphotoxin, and interleukin-1. Diabetes 1988;37:133-136.
32. Campbell IL, Hobbs MV, Dockter J, et al. Islet inflammation and hyperplasia induced by the pancreatic islet specific overexpression of interleukin-6 in transgenic mice. Am J Pathol 1994;145:157-166.
33. Faust A, Rothe H, Schade U, et al. Primary non-function of islet grafts in autoimmune diabetic nonobese diabetic mice is prevented by treatment with interleukin-4 and interleukin-10. Transplantation 1996;62: 648-652.
34. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, et al. Combination therapy with cyclosporine and interleukin-4 or interleukin-10 prolongs survival of syngeneic pancreatic islet grafts in nonobese diabetic mice. Transplantation 1997;64:1525-1531.
35. Kenmochi T. Protection of mouse islet isografts from nonspecific inflammatory damage by recipient treatment with nicotinamide and 15-deoxyspergualin. Cell Transplant 1996;5:41-47.
36. Rabinovitch A, Suarez-Pinzon WL, Strynadka K, et al. Human pancreatic islet beta cell destruction by cytokines is independent of nitric oxide production. J Clin Endocrinol Metab 1994;79:1058-1062.
37. Yamada K, Otabe S, Inada C, et al. Nitric oxide and nitric oxide synthetase mRNA induction in mouse islet cells by interferon-gamma plus tumor necrosis factor-alpha. Biochem Biophy Res Commun 1993;197:22-27.
38. Cetkovic-Cvrlje M, Eizirik DL. TNF-alpha and interferon-gamma potentiate the deleterious effects of IL-1 beta on mouse pancreatic islets mainly via generation of nitric oxide. Cytokine 1994;6:399-406.
39. Stevens RB, Lokeh A, Ansite JD, et al. Role of nitric oxide in the pathogenesis of early pancreatic islet dysfunction during rat and human intraportal islet transplantation. Transplant Proc 1994;26:692.
40. Thomas HE, Darwiche R, Corbett JA, et al. Interleukin-1 plus γ-interferon-induced pancreatic β-cell dysfunction is mediated by β-cell nitric oxide production. Diabetes 2002;51:311-316.
41. Burkart V, Bellman K, Hartmann B, et al. Fusidic acid suppresses nitric oxide toxicity in pancreatic islet cells. Biochem Pharmacol 1994;48:1379-1385.
42. Manning A, Rao A. IKK-1 and IKK-2: cytokine activation IκB kinases essential for NF-κB activation. Science 1997;278:860-866.
43. Contreras JL, Smyth CA, Guadalupe B, et al. Simvastatin induces activation of the serine-threonine protein kinase AKT and increases survival of isolated human pancreatic islets. Transplantation 2002;74:1063-1069.
44. Pahan K, Sheikh FG, Namboodiri A, et al. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthetase and cytokines in rat primary astrocytes, microglia and macrophages. J Clin Invest 1997;100:2671-2679.
45. Arita S, Kasraie A, Une S, et al. Prolongation of islet allograft survival in mice by combined treatment with pravastatin and low-dose cyclosporine. Cell Transplant 2001;10:639-644.
46. Arita S, Nagai T, Ochiai M, et al. Prevention of primary non-function of canine islet autografts by treatment with pravastatin. Transplantation 2002;73:7-12.
47. Contreras JL, Smyth CA, Bilbao G, et al. 17β-estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: molecular mechanisms and islet functionality. Transplantation 2002;74:1252-1259.
48. Ris F, Hammar E, Bosco D, et al. Impact of integrin-matrix inhibition of apoptosis on the survival of purified human beta-cells in vitro. Diabetologia 2002;45:841-850.
49. Guinan EC, Gribben JG, Boussiotis VA, et al. Pivotal role of the B7: CD28 pathway in transplantation tolerance and tumor immunity. Blood 1994;84:3261-3282.
50. Coddington DA, Yang H, Rowden G, et al. Islet allograft rejection in rats: a time course study characterizing adhesion molecule expression, MHC expression, and infiltrate immunophenotypes. Cell Transplant 1998;7:285-297.
51. Katz SM, Tian L, Stepkowski SM, et al. Effect of ICAM-1/LFA-1 blockade on pancreatic islet allograft survival, function, and early cytokine production. Transplant Proc 1997;29:748-749.
52. Kuttler B, Hartmann A, Wanka H. Long-term culture of islets abrogates cytokine-induced or lymphocyte-induced increase of antigen expression on β cells. Transplantation 2002;74:440-445.
53. Gaber AO, Fraga DW, Callicutt CS, et al. Improved in vivo pancreatic islet function after prolonged in vitro islet culture. Transplantation 2001;72:1730-1736.
54. Pileggi A, Molano RD, Berney T, et al. Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 2001;50:1983-1991.
55. Hohmeier HE, Thigpen A, Tran VV, et al. Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1beta induced cytotoxicity and reduces nitric oxide production. J Clin Invest 1998;101:1811-1820.
56. Bottino R, Balamurugan AN, Bertera S, et al. Preservation of human islet cell functional mass by anti-oxidative action of a novel SOD mimic compound. Diabetes 2002;51:2561-2567.
57. George M, Ayuso E, Casellas A, et al. β cell expression of IGF-I leads to recovery from type 1 diabetes. J Clin Invest 2002;109:1153-1163.
58. Contreras JL, Bilbao G, Smyth CA, et al. Cytoprotection of pancreatic islets before and soon after transplantation by gene transfer of the antiapoptotic Bcl-2 gene. Transplantation 2001;71:1015-1023.
59. Gianoukakis N, Rudert WA, Ghivizzani SC, et al. Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1β-induced β-cell impairment and activation of islet cell apoptosis in vitro. Diabetes 1999;48:1730-1736.
60. Gianoukakis N, Rudert WA, Trucco M, et al. Protection of human islets from the effects of Interleukin-1β by adenoviral gene transfer of an IγB repressor. J Biol Chem 2000;275:36509-36513.
61. Weber M, Deng S, Kucher T, et al. Adenoviral transfection of isolated pancreatic islets: a study of programmed cell death ( Apoptosis) and islet function. J Surg Res 1997;69:23-32.
62. Shibata S, Matsumoto S, Sageshima J, et al. Temporary treatment with sirolimus and low-trough cyclosporine prevents acute islet allograft rejection, and combination with starch-conjugated deferoxamine promotes islet engraftment in the preclinical pig model. Transplant Proc 2001;33:509.
63. Paty BW, Harmon JS, Marsh CL, et al. Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. Transplantation 2002;73:353-357.
64. Fu F, Hu S, Deleo J, et al. Long-term islet graft survival in streptozotocin-and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720. Transplantation 2002;73:1425-1430.
65. Shirasugi N, Adams AB, Durham MM, et al. Prevention of chronic rejection in murine cardiac allografts: a comparison of chimerism- and nonchimerism-inducing costimulation blockade-based tolerance induction regimens. J Immunol 2002;169:2677-84.
66. Kenyon NS, Chatzipetrou M, Masetti M, et al. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Nat Acad Sci 1999;96:8132-8137.
67. Ciancio G, Garcia-Morales R, Mathew J. Donor bone marrow infusions are tolerogenic in human renal transplantation. Transplant Proc 2001;33:1295-1296.
68. Inverardi L, Ricordi C. Tolerance and pancreatic islet transplantation. Phil Trans R Soc Lon 2001;356:759-765.
69. Vos P, Hamel AF, Tatarkiewicz K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 2002;45:159-173.
70. Bonner-Weir S, Sharma A. Pancreatic stem cells. J Pathol 2002;197:519-526.
71. Soria B, Skoudy A, Martin F. From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus. Diabetol 2001;44:407-415.
72. Fontaine MJ, Blanchard J, Rastellini C, et al. Pancreatic islets activate portal vein endothelial cells in vitro. Ann Clin Lab Sci 2002;32:352-361.